3.215.190.193
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Inherited Retinal Disease

Gene therapy appears safe, effective in X-linked retinitis pigmentosa

Primary results from the Phase 1/2 study evaluating the investigational gene therapy botaretigene sparoparvovec in patients with the inherited retinal disease X-linked retinitis pigmentosa (XLRP) associated with the retinitis pigmentosa GTPase regulator (RPGR) gene were presented at the AAO 2022 Annual meeting. Treatment with the investigational gene therapy was found...

Read More
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-